Nuveen Asset Management, LLC Sangamo Therapeutics, Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $6,280 - $13,189	20,936 Added 2.92%	737,464 $398,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $1,609 - $4,079	-2,775 Reduced 0.39%	716,528 $429,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $737,401 - $1.16 Million	-664,326 Reduced 48.01%	719,303 $935,000
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $3.24 Million - $7.15 Million	-1,948,972 Reduced 58.48%	1,383,629 $2.44 Million
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $64,341 - $117,765	-23,228 Reduced 0.69%	3,332,601 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $9.68 Million - $14.5 Million	2,267,632 Added 208.38%	3,355,829 $16.4 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $472,352 - $894,302	-144,010 Reduced 11.69%	1,088,197 $4.51 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $338,166 - $505,633	-64,659 Reduced 4.99%	1,232,207 $7.12 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $1 Million - $1.51 Million	-137,659 Reduced 9.6%	1,296,866 $9.26 Million
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $325,071 - $433,308	36,079 Added 2.58%	1,434,525 $13.7 Million
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $609,213 - $757,173	-59,903 Reduced 4.11%	1,398,446 $16.7 Million
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $196,808 - $308,417	18,089 Added 1.26%	1,458,349 $18.3 Million
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $680,703 - $1.34 Million	73,749 Added 5.4%	1,440,260 $22.5 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $6.22 Million - $8.27 Million	662,875 Added 94.21%	1,366,511 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $163,757 - $311,957	26,370 Added 3.89%	703,636 $6.3 Million
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $482,689 - $845,900	-95,582 Reduced 12.37%	677,266 $4.31 Million
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $259,666 - $378,342	32,337 Added 4.37%	772,848 $6.47 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $454,047 - $613,089	-50,171 Reduced 6.35%	740,511 $6.7 Million
Q2 2019 Aug 15, 2019	BUY	$8.75 - $13.03 $6.92 Million - $10.3 Million	790,682 New	790,682 $8.52 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account